ArticlePharmaceutics2026

Assessment of pH-Responsive Ionisable Lipid Nanoparticles as Cisplatin Delivery Vehicles for Treating Cisplatin-Resistant Ovarian Cancer.

Sarigama Rajesh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.